About the company
Algentech develops and commercializes plant gene editing technologies for industrial and research applications. Our proprietary technologies form unique tools for precise engineering of nuclear and organelle (chloroplast and mitochondria) genomes with multi-sectorial applications. The company was incorporated in Evry, France in March 2009 and is a member of the leading French biocluster Génopole. Our research and development laboratories are located at INRA (Versailles, France), a world renowned center for applied agricultural research.
Corporate Advisory Committee
Paul Bruma, XMP BA
Gérard Cachier, XMP BA
Michel Martin, Invest-Y BA
Nathalie Ricoeur-Nicolai, Scientipole Capital
Frédéric Zampatti, Génopole
Alexander Sorokin, president and CEO. Dr Sorokin has more than 20 years experience in plant genetics, agronomy and biotechnology. Prior to founding Algentech he held the position of senior research associate at the Sainsbury Laboratory (Norwich, UK), in charge of developing technologies. He holds a doctorate in plant genetics obtained in 1991 from the school of Agronomy in Minsk for his work on wheat and triticale genetics.
Isabelle Malcuit, director and CSO. Dr Malcuit has extensive experience in plant genetics and biotechnology. Prior to founding Algentech, she held the position of senior research associate at the Sainsbury Laboratory (Norwich, UK), in charge of a programme for identification of genes involved in plant pathogen resistance and susceptibility. She holds a PhD in plant virology received in 1998 from the department of genetics, Trinity College (Dublin, Ireland) for her work on potato viruses.